The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
The role of antigen presenting cells in multiple sclerosis
Open accessAbstract
Multiple Sclerosis (MS) is a debilitating T cell-mediated autoimmune disease of the central nervous system (CNS). Animal models of MS, such as experimental autoimmune encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus-Induced demyelinating disease (TMEV-IDD) have given light to cellular mechanisms involved in the initiation and progression of this organ-specific autoimmune disease. Within the CNS, antigen presenting cells (APC) such as microglia and astrocytes participate as first line defenders against infections or inflammation. However, during chronic inflammation they can participate in perpetuating the self-destructive environment by secretion of inflammatory factors and/or presentation of myelin epitopes to autoreactive T cells. Dendritic cells (DC) are also participants in the presentation of antigen to T cells, even within the CNS. While the APCs alone are not solely responsible for mediating the destruction to the myelin sheath, they are critical players in perpetuating the inflammatory milieu. This review will highlight relevant studies which have provided insight to the roles played by microglia, DCs and astrocytes in the context of CNS autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Innate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“Myelin is an extension of oligodendrocytes, whichwraps tightly around the axon of a neuron, providing insulation for fast electrical conduction [3,4].”
Cited by
Role of neuroinflammation in neurodegenerative diseases (Review)
CHEN, W.-W., ZHANG, X., & HUANG, W.-J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4948 · Cited by 932
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
“ROCK inhibitor Fasudil converts microglia from M1 to M2 by suppressing NF-κB, both in vitro and in vivo, thus attenuating demyelination and neuroinflammation, and promoting neuroprotection as well as reducing the severity of EAE (Zhang et al., 2013; Chen et al., 2014).”
BackgroundSingle-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
Jordão, M. J. C., Sankowski, R., Brendecke, S. M., Sagar, Locatelli, G., Tai, Y.-H., Tay, T. L., Schramm, E., Armbruster, S., Hagemeyer, N., et al. (2019) · Science · doi:10.1126/science.aat7554 · Cited by 843
“Antigen presentation to T cells has been shown in vivo for leptomeningeal myeloid cells (4, 19) and in vitro for several myelomonocytic populations (42).”
BackgroundGlial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 544
Role of microglia in CNS inflammation
Graeber, M. B., Li, W., & Rodriguez, M. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.033 · Cited by 392
“Astrocytes are not commonly associated with immunological reactions and it is well accepted that their role in CNS immunity is largely regulatory while their contribution and capacity to present antigen and activate T cells are still controversial [63].”
BackgroundInfluentialVirus infection, antiviral immunity, and autoimmunity
Getts, D. R., Chastain, E. M. L., Terry, R. L., & Miller, S. D. (2013) · Immunological Reviews · doi:10.1111/imr.12091 · Cited by 299
Self-citationThe neurobiological basis of narcolepsy
Mahoney, C. E., Cogswell, A., Koralnik, I. J., & Scammell, T. E. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0097-x · Cited by 289
Morizane, A., Doi, D., Kikuchi, T., Okita, K., Hotta, A., Kawasaki, T., Hayashi, T., Onoe, H., Shiina, T., Yamanaka, S., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.007 · Cited by 275
Axon growth inhibition by RhoA/ROCK in the central nervous system
Fujita, Y., & Yamashita, T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00338 · Cited by 269
T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases
González, H., & Pacheco, R. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0201-8 · Cited by 266
The Role of Astrocytes in Multiple Sclerosis Progression
Correale, J., & Farez, M. F. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00180 · Cited by 261
Brambilla, R. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01980-7 · Cited by 246
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation
Xiao, Y., Jin, J., Chang, M., Chang, J.-H., Hu, H., Zhou, X., Brittain, G. C., Stansberg, C., Torkildsen, Ø., Wang, X., et al. (2013) · Nature Medicine · doi:10.1038/nm.3111 · Cited by 184
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Microglia plasticity during health and disease: An immunological perspective
Shemer, A., Erny, D., Jung, S., & Prinz, M. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.003 · Cited by 168
Lodygin, D., Odoardi, F., Schläger, C., Körner, H., Kitz, A., Nosov, M., van den Brandt, J., Reichardt, H. M., Haberl, M., & Flügel, A. (2013) · Nature Medicine · doi:10.1038/nm.3182 · Cited by 144
Allan, E. R. O., Tailor, P., Balce, D. R., Pirzadeh, P., McKenna, N. T., Renaux, B., Warren, A. L., Jirik, F. R., & Yates, R. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302896 · Cited by 95
Inflammation as common link to progressive neurological diseases
Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03628-8 · Cited by 60
Immune-mediated processes in neurodegeneration: where do we stand?
Fakhoury, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8052-0 · Cited by 43
“In contrast to astrocytes, microglia serve as poor antigen presenting cells due to their low expression of MHC class II proteins [29],”
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis
Shin, S., Walz, K. A., Archambault, A. S., Sim, J., Bollman, B. P., Koenigsknecht-Talboo, J., Cross, A. H., Holtzman, D. M., & Wu, G. F. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.03.010 · Cited by 32
“Of the numerous APCs that are capable of driving adaptive immune responses during EAE, dendritic cells (DCs) have been shown to perform critical APC functions during every phase of EAE (Deshpande et al., 2007; Wu and Laufer, 2007; Chastain et al., 2011; Ji et al., 2013).”
BackgroundGlial cells as therapeutic targets in progressive multiple sclerosis
Wilbanks, B., Maher, L., & Rodriguez, M. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1614443 · Cited by 17
“They are capable of expressing antigens with major histocompatibility complex (MHC) class I and II proteins and can therefore elicit an immune response from CD4 + Th1 or CD8 + cells upon stimulation by proinflammatory cytokines [67,68].”
BackgroundWhite Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
“DCs process myelin antigens such as myelin basic protein (MBP), proteolipid protein (PLP), and myelin oligodendrocyte glycoprotein (MOG) [50], thereby presenting peptide-MHC-II complexes to naïve CD4 + T cells through their T cell receptor (TCR) [51].”
Metadata
- Authors
- Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 1812
- Issue
- 2
- Pages
- 265-274
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2116041320
- Cited by
- 266
- References
- 153
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.